RenovoRx Statistics
Share Statistics
RenovoRx has 36.65M
shares outstanding. The number of shares has increased by 52.68%
in one year.
| 36.65M |
| 52.68% |
| 0.2% |
| 32.09% |
| 30.08M |
| 13,170 |
| 3.3% |
Short Selling Information
The latest short interest is 273.55K, so 0.75% of the outstanding
shares have been sold short.
| 273.55K |
| 0.75% |
| 0.78% |
| 1 |
Valuation Ratios
The PE ratio is -3.45 and the forward
PE ratio is -3.94.
RenovoRx's PEG ratio is
0.13.
| -3.45 |
| -3.94 |
| 708.18 |
| 8.9 |
| 6.8 |
| -3.33 |
| 0.13 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for RenovoRx.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 4.1,
with a Debt / Equity ratio of 0.06.
| 4.1 |
| 4.1 |
| 0.06 |
| -0.03 |
| -0.03 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $4.3K |
| $-881.4K |
| 10 |
| 0.01 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by 23.3% in the
last 52 weeks. The beta is 1.3, so RenovoRx's
price volatility has been higher than the market average.
| 1.3 |
| 23.3% |
| 1.15 |
| 1.17 |
| 55.3 |
| 399,190 |
Income Statement
In the last 12 months, RenovoRx had revenue of 43K
and earned -8.81M
in profits. Earnings per share was -0.37.
| 43K |
| 43K |
| -10.97M |
| -8.81M |
| -10.97M |
| -10.97M |
| -0.37 |
Full Income Statement Balance Sheet
The company has 7.15M in cash and 278K in
debt, giving a net cash position of 6.88M.
| 7.15M |
| 278K |
| 6.88M |
| -50.22M |
| 13.64M |
| 11.84M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -9.13M
and capital expenditures -12K, giving a free cash flow of -9.14M.
| -9.13M |
| -12K |
| -9.14M |
| -0.39 |
Full Cash Flow Statement Margins
Gross margin is 100%, with operating and profit margins of -25511.63% and -20497.67%.
| 100% |
| -25511.63% |
| -20497.67% |
| -20497.67% |
| -25511.63% |
| -25511.63% |
| -21248.84% |